美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

DAMORA THERAPEUT

23.05

+4.9127.07%

盤前：22.86-0.1900-0.82%08:57 EDT

成交量：33.79萬

成交額：718.94萬

市值：13.89億

市盈率：-0.15

高：23.18

開：17.81

低：17.66

收：18.14

52周最高：38.33

52周最低：2.01

股本：6,024.01萬

流通股本：5,114.08萬

量比：0.72

換手率：0.66%

股息：- -

股息率：- -

每股收益(TTM):-153.9532

每股收益(LYR):-18.5274

淨資產收益率：-163.80%

總資產收益率：-16.46%

市淨率：-7.90

市盈率(LYR):-1.24

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

DAMORA THERAPEUT

交易所：

NASDAQ

成立時間：

2011

員工人數：

5

公司地址：

Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States

官網：

http://www.damoratx.com

郵編：

02453

電話：

傳真：

- -

簡介：

Damora Therapeutics, Inc.於2019年10月在特拉華州註冊成立，是一家專註於重新定義血液系統疾病患者治療方案的創新型生物技術公司。該公司正在推進新一代生物製劑的研發，旨在治療突變鈣網蛋白驅動的骨髓增生性腫瘤，包括原發性血小板增多症和骨髓纖維化，這些疾病亟需能夠改善病情的治療方案。Damora的多個項目展現出同類最佳的潛力，並計劃於2026年進入臨床開發階段。公司的目標是快速推出優化療法，這些療法不僅覆蓋廣泛的突變類型，而且使用極其便捷，最終目標是顯著改善患者的治療效果。

董事

名稱

職位

Carl Goldfischer

Director and Chair of the Board

Amit D. Munshi

Director

Chris Cain

Director

Jayson Dallas

Director

Julianne Bruno

Director

Peter Harwin

Director

股東

名稱

職位

Sherwin Sattarzadeh

Chief Operating Officer and Interim Principal Executive Officer

Lori Firmani

Interim Chief Financial Officer

Garrett Winslow

General Counsel

Matthew Kronmiller

Executive Vice President of Strategy and Chief Business Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DMRA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":23.05,"timestamp":1774296000000,"preClose":18.14,"halted":0,"volume":337881,"hourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":23.05,"latestTime":"08:57 EDT","volume":157,"amount":3600.224462,"timestamp":1774357033113,"change":-0.19,"changeRate":-0.008243,"amplitude":0.010846},"delay":0,"changeRate":0.27067254685777287,"floatShares":51140800,"shares":60240100,"eps":-153.95322,"marketStatus":"盤前交易","change":4.91,"latestTime":"03-24 09:16:17 EDT","open":17.81,"high":23.18,"low":17.655,"amount":7189378.870683,"amplitude":0.304576,"askPrice":28.01,"askSize":800,"bidPrice":17.36,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-153.95322,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":23.05,"preHourTrading":{"tag":"盘前","latestPrice":22.86,"preClose":23.05,"latestTime":"08:57 EDT","volume":157,"amount":3600.224462,"timestamp":1774357033113,"change":-0.19,"changeRate":-0.008243,"amplitude":0.010846},"postHourTrading":{"tag":"盘后","latestPrice":23.1644,"preClose":23.05,"latestTime":"19:10 EDT","volume":667,"amount":15430.0055,"timestamp":1774307401144,"change":0.1144,"changeRate":0.004963,"amplitude":0.004963},"volumeRatio":0.7245136542319823},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":51140800,"roa":"-16.46%","roe":"-163.80%","lyrEps":-18.527432,"volumeRatio":0.7245136542319823,"shares":60240100,"dividePrice":0,"high":23.18,"amplitude":0.304576,"preClose":18.14,"low":17.655,"week52Low":2.01,"pbRate":"-7.90","week52High":38.3251,"institutionHeld":0,"latestPrice":23.05,"eps":-153.95322,"divideRate":0,"volume":337881,"delay":0,"ttmEps":-153.95322,"open":17.81,"prevYearClose":23.01,"prevWeekClose":18.14,"prevMonthClose":29.58,"prevQuarterClose":23.01,"fiveDayClose":24.98,"twentyDayClose":29.78,"sixtyDayClose":29.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92},{"market":"US","date":"2025-03-19","symbol":"DMRA","fiscalQuarterEnding":"2024/12","expectedEps":-3.12,"name":null,"time":"盤後","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":-5.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-03-20","current":-0.149721,"percent":1,"low":-100.260711,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"high":-72.999835,"avg":-92.162291,"sd":9.56252,"marketCap":1156609382},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382}],"updateTime":1774339744195},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":154090027,"yearFounded":2011,"employeeNum":5,"address":"Building 23,Suite 105,221 Crescent Street,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"781 281 9020"},"stockCompanyDetail":{"websiteUrl":"http://www.damoratx.com","stockEarnings":[{"period":"1week","weight":-0.0773},{"period":"1month","weight":-0.2317},{"period":"3month","weight":-0.2074},{"period":"6month","weight":4.4108},{"period":"1year","weight":2.7787},{"period":"ytd","weight":0.0017}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Damora Therapeutics, Inc.於2019年10月在特拉華州註冊成立，是一家專註於重新定義血液系統疾病患者治療方案的創新型生物技術公司。該公司正在推進新一代生物製劑的研發，旨在治療突變鈣網蛋白驅動的骨髓增生性腫瘤，包括原發性血小板增多症和骨髓纖維化，這些疾病亟需能夠改善病情的治療方案。Damora的多個項目展現出同類最佳的潛力，並計劃於2026年進入臨床開發階段。公司的目標是快速推出優化療法，這些療法不僅覆蓋廣泛的突變類型，而且使用極其便捷，最終目標是顯著改善患者的治療效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.139908},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.041874},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.124567},{"month":4,"riseRate":0,"avgChangeRate":-0.128225},{"month":5,"riseRate":0.4,"avgChangeRate":-0.011355},{"month":6,"riseRate":0.6,"avgChangeRate":0.064068},{"month":7,"riseRate":0.4,"avgChangeRate":0.030923},{"month":8,"riseRate":0.4,"avgChangeRate":-0.123358},{"month":9,"riseRate":0.6,"avgChangeRate":0.012323},{"month":10,"riseRate":0.4,"avgChangeRate":0.0502},{"month":11,"riseRate":0.5,"avgChangeRate":0.174574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.010261}],"exchange":"NASDAQ","name":"DAMORA THERAPEUT","nameEN":"DAMORA THERAPEUT"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":{"directors":[{"name":"Carl Goldfischer","position":"Director and Chair of the Board"},{"name":"Amit D. Munshi","position":"Director"},{"name":"Chris Cain","position":"Director"},{"name":"Jayson Dallas","position":"Director"},{"name":"Julianne Bruno","position":"Director"},{"name":"Peter Harwin","position":"Director"}],"executives":[{"name":"Sherwin Sattarzadeh","position":"Chief Operating Officer and Interim Principal Executive Officer"},{"name":"Lori Firmani","position":"Interim Chief Financial Officer"},{"name":"Garrett Winslow","position":"General Counsel"},{"name":"Matthew Kronmiller","position":"Executive Vice President of Strategy and Chief Business Officer"}]}}}